145 related articles for article (PubMed ID: 1773296)
21. A critical reevaluation of nocturnal penile tumescence monitoring in the diagnosis of erectile dysfunction.
Meisler AW; Carey MP
J Nerv Ment Dis; 1990 Feb; 178(2):78-89. PubMed ID: 2405102
[TBL] [Abstract][Full Text] [Related]
22. Visual sexual stimulation plethysmography: complementary test to nocturnal penile plethysmography.
Opsomer RJ; Wese FX; Van Cangh PJ
Urology; 1990 Jun; 35(6):504-7. PubMed ID: 2353377
[TBL] [Abstract][Full Text] [Related]
23. Changes in penile sensitivity following papaverine-induced erection in sexually functional and dysfunctional men.
Rowland DL; Leentvaar EJ; Blom JH; Slob AK
J Urol; 1991 Oct; 146(4):1018-21. PubMed ID: 1895416
[TBL] [Abstract][Full Text] [Related]
24. Infusion pharmacocavernosometry and nocturnal penile tumescence findings in men with erectile dysfunction.
Montague DK; Lakin MM; VanderBurg Mendendorp S; Tesar LJ
J Urol; 1991 Apr; 145(4):768-71. PubMed ID: 2005697
[TBL] [Abstract][Full Text] [Related]
25. The effects of a new alpha-2 adrenoceptor antagonist on sleep and nocturnal penile tumescence in normal male volunteers and men with erectile dysfunction.
Bancroft J; Munoz M; Beard M; Shapiro C
Psychosom Med; 1995; 57(4):345-56. PubMed ID: 7480564
[TBL] [Abstract][Full Text] [Related]
26. Visual stimulation facilitates penile responses to vibration in men with and without erectile disorder.
Janssen E; Everaerd W; van Lunsen RH; Oerlemans S
J Consult Clin Psychol; 1994 Dec; 62(6):1222-8. PubMed ID: 7860820
[TBL] [Abstract][Full Text] [Related]
27. The effects of testosterone administration and visual erotic stimuli on nocturnal penile tumescence in normal men.
Carani C; Scuteri A; Marrama P; Bancroft J
Horm Behav; 1990 Sep; 24(3):435-41. PubMed ID: 2227854
[TBL] [Abstract][Full Text] [Related]
28. Testosterone and erectile function, nocturnal penile tumescence and rigidity, and erectile response to visual erotic stimuli in hypogonadal and eugonadal men.
Carani C; Bancroft J; Granata A; Del Rio G; Marrama P
Psychoneuroendocrinology; 1992 Nov; 17(6):647-54. PubMed ID: 1287683
[TBL] [Abstract][Full Text] [Related]
29. [Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction].
Porst H
Urologe A; 1988 Jan; 27(1):22-6. PubMed ID: 3284144
[TBL] [Abstract][Full Text] [Related]
30. [The intracavernosal administration of papaverine in the diagnosis and treatment of sexual disorders in men].
Gorpinchenko II; Khudaĭberdiev NA
Vrach Delo; 1989 Oct; (10):102-5. PubMed ID: 2617964
[TBL] [Abstract][Full Text] [Related]
31. Enhanced pharmacological testing in patients with erectile dysfunction.
Vruggink PA; Diemont WL; Debruyne FM; Meuleman EJ
J Androl; 1995; 16(2):163-8. PubMed ID: 7559147
[TBL] [Abstract][Full Text] [Related]
32. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
Purvis K; Brekke I; Christiansen E
Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
[TBL] [Abstract][Full Text] [Related]
33. Intracavernous injections of papaverine and phentolamine: correlation with penile brachial index.
Lakin MM; Montague DK
Urology; 1989 May; 33(5):383-6. PubMed ID: 2775361
[TBL] [Abstract][Full Text] [Related]
34. Intracavernosal papaverine and phentolamine for the medical management of erectile dysfunction in a genitourinary clinic.
Armstrong DK; Convery A; Dinsmore WW
Int J STD AIDS; 1993; 4(4):214-6. PubMed ID: 8399501
[TBL] [Abstract][Full Text] [Related]
35. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
[TBL] [Abstract][Full Text] [Related]
36. RigiScan data under long-term testosterone therapy: improving long-term blood circulation of penile arteries, penile length and girth, erectile function, and nocturnal penile tumescence and duration.
Canguven O; Talib RA; El-Ansari W; Shamsoddini A; Salman M; Al-Ansari A
Aging Male; 2016 Dec; 19(4):215-220. PubMed ID: 27690744
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of erectile responses to vasoactive drugs by a variable amplitude oscillation device.
Chun SS; Fenemore J; Heaton JP; Johnston B; Morales A
Int J Impot Res; 1996 Dec; 8(4):221-5. PubMed ID: 8981171
[TBL] [Abstract][Full Text] [Related]
38. [Comparison between nocturnal penile tumescence (NPT) and artificial full erection].
Aoki M; Kumamoto Y; Mori K; Yamaguti Y; Sato Y
Hinyokika Kiyo; 1988 May; 34(5):825-31. PubMed ID: 3177125
[TBL] [Abstract][Full Text] [Related]
39. Comparative study between audiovisualsexual stimulation test and nocturnal penile tumescence test using RigiScan Plus in the evaluation of erectile dysfunction.
Mizuno I; Fuse H; Fujiuchi Y; Nakagawa O; Akashi T
Urol Int; 2004; 72(3):221-4. PubMed ID: 15084766
[TBL] [Abstract][Full Text] [Related]
40. Can an intracavernous papaverine injection be used to diagnose arteriogenic impotence?
Imagawa A; Kawanishi Y
Hinyokika Kiyo; 1988 Jul; 34(7):1185-9. PubMed ID: 3177140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
